| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/02/2009 | WO2009082648A1 Stabilized factor ix formulations containing trehalose |
| 07/02/2009 | WO2009082641A2 Compositions and methods for treating diseases associated with angiogenesis and inflammation |
| 07/02/2009 | WO2009082514A1 Molecular targets for treatment of inflammation |
| 07/02/2009 | WO2009082485A1 Anti-c35 antibody combination therapies and methods |
| 07/02/2009 | WO2009082426A1 Method of stimulating the motility of the gastrointestinal system using ipamorelin |
| 07/02/2009 | WO2009082354A1 Cross-linked hydrogel containing an active substance |
| 07/02/2009 | WO2009081991A1 Therapeutic agent for cerebral ischemic injury |
| 07/02/2009 | WO2009081958A1 Glycosylated glycopeptide antibiotic derivative |
| 07/02/2009 | WO2009081955A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa |
| 07/02/2009 | WO2009081782A1 N-pyrazole-2-pyridinecarboxamide derivative |
| 07/02/2009 | WO2009081395A1 A method of treating neurodegenerative diseases |
| 07/02/2009 | WO2009081374A2 Cosmetic use of plakoglobin-type proteins |
| 07/02/2009 | WO2009081368A2 Cosmetic use desmoglein i-type proteins |
| 07/02/2009 | WO2009081274A2 Mutant forms of streptolysin o |
| 07/02/2009 | WO2009081170A2 Peptide fusion proteins |
| 07/02/2009 | WO2009081152A2 Antimicrobial compounds |
| 07/02/2009 | WO2009081114A1 Fusion proteins comprising an slrp-derived anti-angiogenic sequence |
| 07/02/2009 | WO2009080914A2 Method for stimulating the proliferation of differentiated cells belonging to the chondrogenic lineage |
| 07/02/2009 | WO2009080899A2 Products and methods affecting cell and tissue growth |
| 07/02/2009 | WO2009080898A2 Products and methods for preventing tumour growth |
| 07/02/2009 | WO2009080852A1 Rplp1-based antitumour compounds |
| 07/02/2009 | WO2009080837A1 Medicament for the treatment of cancer of the pancreas |
| 07/02/2009 | WO2009080810A1 New polypeptides having affinity for her2 |
| 07/02/2009 | WO2009080778A2 Preparations with rosehip extracts, and method of producing rosehip extracts |
| 07/02/2009 | WO2009080699A2 Peg-interferon-beta formulations |
| 07/02/2009 | WO2009080608A1 Y2 receptor agonists |
| 07/02/2009 | WO2009080447A1 Edible product having an immunostimulating effect |
| 07/02/2009 | WO2009080313A2 Early administration of botulinum toxin in the treatment of cerebrovascular event and spinal cord injury |
| 07/02/2009 | WO2009080299A1 Sm-protein based secretion engineering |
| 07/02/2009 | WO2009080272A1 Use of a neurotoxic component of a clostridium botulinum toxin complex to reduce or prevent side effects |
| 07/02/2009 | WO2009080164A1 Solid lipid microcapsules containing growth hormone in the inner solid core |
| 07/02/2009 | WO2009080054A1 Protease inhibitor |
| 07/02/2009 | WO2009080032A1 Compressed chewing gum comprising a systemically active small peptide |
| 07/02/2009 | WO2009080024A1 Compressed chewing gum comprising an incretin mimetic |
| 07/02/2009 | WO2009080023A1 Compressed chewing gum comprising peptide |
| 07/02/2009 | WO2009079837A1 A pharmaceutical formulation containing recombinant human serum albumin-interferon alpha fusion protein |
| 07/02/2009 | WO2009079792A1 Recovery of hydrophobic peptides from oils |
| 07/02/2009 | WO2009079690A1 Haemostasis- modulating compositions and uses therefor |
| 07/02/2009 | WO2009064819A3 Compositions for the treatment of gastrointestinal inflammation |
| 07/02/2009 | WO2009063221A3 Methods of treating or preventing inflammatory diseases of the intestinal tract |
| 07/02/2009 | WO2009045596A3 Optimized dengue virus entry inhibitory peptide (10an) |
| 07/02/2009 | WO2009036448A3 Natriuretic peptide receptor-c agonists |
| 07/02/2009 | WO2009036149A9 Methods for treatment of degenerative disease associated with apoptosis |
| 07/02/2009 | WO2009036059A3 Novel stat3 pathway inhibitors and cancer stem cell inhibitors |
| 07/02/2009 | WO2009033762A3 Use of endothelin-3 as a therapeutic agent |
| 07/02/2009 | WO2009033739A3 Use of a peptide as a therapeutic agent |
| 07/02/2009 | WO2009033678A3 Use of a tuftsin as a therapeutic agent |
| 07/02/2009 | WO2008155403A3 Use of leptin in the prevention of unhealthy food habits and cardiovascular diseases |
| 07/02/2009 | WO2008148068A8 Multicistronic vectors and methods for their design |
| 07/02/2009 | WO2008142198A3 A method for inhibiting or stimulating angiogenesis in an individual |
| 07/02/2009 | WO2008031009A3 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders |
| 07/02/2009 | WO2007141005A8 Use of glutamyl aminopeptidase (enpep) as a therapeutic or diagnostic target |
| 07/02/2009 | US20090171262 Method and Mixture for In Vivo Photochemical Cross-Linking of Collagen |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170786 Methods for the use of branched chain amino acids |
| 07/02/2009 | US20090170785 Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application |
| 07/02/2009 | US20090170784 Crystalline and amorphous forms of peptide |
| 07/02/2009 | US20090170783 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors |
| 07/02/2009 | US20090170782 Gnrh Analogue Formulations |
| 07/02/2009 | US20090170781 Identification of Immunologically Effective Epitopes on the Surface of Red Blood Cells and Their Use in a Method of Inducing Tolerance Thereto |
| 07/02/2009 | US20090170780 Protection of the retina against laser injury by nap and related peptides |
| 07/02/2009 | US20090170779 cell adhesion molecule determined to effect platelet aggregation, secretion, platelet spreading and cellular adhesion; thrombosis, atherosclerosis, heart attacks, stroke and other clinical disorders involving thrombus formation |
| 07/02/2009 | US20090170778 PYY Agonists and Uses Thereof |
| 07/02/2009 | US20090170777 Hsp therapy in conjunction with a low antigenicity diet |
| 07/02/2009 | US20090170776 Angiogenically effective unit dose of fgf and method of administering |
| 07/02/2009 | US20090170775 Vasoactive intestinal polypeptide compositions |
| 07/02/2009 | US20090170774 Compositions and methods for enhancing fertility |
| 07/02/2009 | US20090170773 Novel use of g-protein-conjugated receptor and ligand thereof |
| 07/02/2009 | US20090170772 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator |
| 07/02/2009 | US20090170771 Anti-angiogenic agents and methods of their use |
| 07/02/2009 | US20090170770 Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap 1) inhibitor |
| 07/02/2009 | US20090170769 Cell surface receptor isoforms and methods of identifying and using the same |
| 07/02/2009 | US20090170768 Water-soluble carbon nanotube compositions for drug delivery and medicinal applications |
| 07/02/2009 | US20090170767 Soluble Endoglin Compounds for the Treatment and Prevention of Cancer |
| 07/02/2009 | US20090170766 Chimeric Kunitz Domains and their Use |
| 07/02/2009 | US20090170765 Peptide for inhibition of calcineurin |
| 07/02/2009 | US20090170764 Compositions containing anti-hiv peptides and methods for use |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170762 Treatment of Diabetes Related Obesity |
| 07/02/2009 | US20090170761 Sustained release preparation of pro-insulin c-peptide |
| 07/02/2009 | US20090170760 Anti-Cancer Agent Comprising Protein C Inhibitor |
| 07/02/2009 | US20090170759 Neuroprotective peptides |
| 07/02/2009 | US20090170758 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties |
| 07/02/2009 | US20090170757 Methods of using macrocyclic modulators of the ghrelin receptor |
| 07/02/2009 | US20090170756 Chimeric natriuretic peptides |
| 07/02/2009 | US20090170755 Cyclic Peptide Compounds |
| 07/02/2009 | US20090170754 Treating liver diseases |
| 07/02/2009 | US20090170753 Capsofungin formulations |
| 07/02/2009 | US20090170752 Reversal Of Adult Onset Disorders With Granulocyte-Colony Stimulating Factors |
| 07/02/2009 | US20090170751 Formation of superfibronectin by BBK32 and uses therefor |
| 07/02/2009 | US20090170750 Single-Chain Insulin |
| 07/02/2009 | US20090170749 Novel Compounds Which Interact With PEA-15 |
| 07/02/2009 | US20090170748 Plasmid mediated supplementation for treating chronically ill subjects |
| 07/02/2009 | US20090170201 Compositions and methods of making embryonic stem cells |
| 07/02/2009 | US20090170197 Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R) |
| 07/02/2009 | US20090170196 Cancer treatment using c-type natriuretic peptide |
| 07/02/2009 | US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 07/02/2009 | US20090170158 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/02/2009 | US20090170146 Novel Carboxylesterase Nucleic Acid Molecules, Proteins and Uses Thereof |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |